Injective (INJ) Holders Stuck at Break-Even: Waiting for Push to $44 Next?
The Injective (INJ) price dynamics reveal that 83% of active holders are at break-even, hinting they're awaiting a price rebound. Concurrently, INJ's active addresses have recently increased after a late March dip.